Home Biotechnology News

Biotechnology News

HART KD a Highly Accurate, Artificial Intelligence-driven Blood Test for Kawasaki Disease

The company used their long-standing, certified laboratory partner, Myriad RBM, to conduct protein measurements on blood samples collected from children with Kawasaki disease and is developing commercial options for offering HART KD for children suspected of Kawasaki disease.

Agendia Presents New Data Demonstrating MammaPrint’s Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients at the European Society for Medical Oncology...

Agendia notes this study confirms findings from the STO-3 Trial, previously published in 2017 in JAMA Oncology, and continues to show that the use of MammaPrint to stratify patient populations could help prevent the overtreatment of breast cancer patients.

BioPorto Plans Initial Clinical Evaluation of gRAD-based Test for Rapid Detection of COVID-19 Virus

BioPorto notes it is designed to provide a qualitative result in under 10 minutes from a minimally invasive sample, and to be easily administered at the point of care, the test could provide a much-needed solution to help improve access to viral testing.

Progentec Diagnostics Announces Launch of Novel Test That Anticipates Onset of Lupus-Related Flares

The aiSLE™ DX Flare Risk Index uses a set of blood-based biomarkers that are measurably altered before the onset of flare symptoms in patients with systemic lupus erythematosus.

Cernostics and Deciphex Strategic Collaboration – To Evaluate the Use of AI-Driven Image Analysis Tools and Technology to Improve Upon Early Detection of Cancer...

This collaboration combines the technological resources of both companies and will apply these to one of the world's largest cohorts of Barrett's esophagus patients with clinical outcome data, including patients who progressed to esophageal cancer.

Fibralign Announces CE Mark Approval for BioBridge®

BioBridge is classified as a Class III device with an indication for use to support lymphatic tissue repair and can be used after or in conjunction with surgical procedures addressing lymphedema.

Aegea Biotechnologies Advances to Semi-Finals of the $5M XPRIZE Rapid COVID Testing Competition

Aegea Biotechnologies notes XPRIZE is renowned for its worldwide competitions to solve humanity's most important challenges. The $5 million, XPRIZE Rapid COVID Testing competition was launched this summer to accelerate the development of high-quality COVID-19 testing that is affordable, easy to use, and that has a fast turnaround time.

ARUP Laboratories Now Offers COVID-19 Saliva Testing – Available with Preapproval to ARUP Clients Nationwide

ARUP Laboratories will perform the test only on saliva specimens collected using an ARUP collection kit with a healthcare provider present. ARUP validated the test using its kit on high-throughput instruments, and cannot perform it on other saliva specimens without jeopardizing quick turnaround times, said Adam Barker, Ph.D., director of ARUP's new COVID-19 Rapid Response Lab.